Toshiba Introduces New Premium Mid-Sized Ultrasound System

* Reuters is not responsible for the content in this press release.

Mon Nov 2, 2009 6:00am EST

Aplio MX Offers Hospitals Exceptional Value with Advanced Clinical Performance
and Improved Portability


TUSTIN, Calif.--(Business Wire)--
Hospitals use ultrasound as a first-line diagnostic exam, requiring them to have
cutting-edge ultrasound technology available to quickly and efficiently perform
a range of patient exams. To meet these demanding clinical needs, while also
considering the financial challenges facing many hospitals today, Toshiba
America Medical Systems, Inc. has introduced the AplioTM MX ultrasound system, a
compact system that offers premium clinical performance and high-end features at
an affordable price point. 

With the Aplio MX, hospitals will be able to complete advanced ultrasound exams,
usually performed with larger, more expensive ultrasound systems, using this
smaller, less expensive system without sacrificing quality. The Aplio MX is
commercially available now. 

"Toshiba is dedicated to listening to our customers and developing comprehensive
imaging systems to meet a range of customer needs and offer the greatest value
at every price point," explained Girish Hagan, vice president, Marketing,
Toshiba. "Toshiba`s Aplio MX offers exceptional value by enabling hospitals to
perform high-end radiology exams with more portability and better patient
access, with a smaller, less expensive system." 

The Aplio MX is approximately 30 percent lighter than traditional cart-based
systems and improves ergonomics with its 19-inch flexible monitor and
customizable key console. It can also include Toshiba`s iAssistTM technology,
which pre-registers frequently used protocols into the system, saving time
during exams and increasing productivity for facilities performing multiple
exams daily. 

Toshiba`s Aplio MX ultrasound system includes:

* 4D imaging to produce high resolution renderings and arbitrary volume cuts in
real-time or offline allowing virtual reconstruction in formats similar to CT
and MRI. 
* Differential Tissue Harmonic Imaging for the better imaging of
difficult-to-image patients, like bariatric, without sacrificing resolution to
give superior border and tissue definition. 
* ApliPure to enhance both image clarity and detail definition with real-time
compounding technology to simultaneously perform spatial and frequency
compounding during transmitting and receiving. 
* Advanced Dynamic Flow to provide color Doppler imaging at an unprecedented
level and show flow with directional information for even the smallest vessels. 
* Precision Imaging to provide more detailed ultrasound images by capturing
information from multiple lines to improve definition of the structure and
minimizing noise and clutter.

The Aplio MX is the latest addition to Toshiba`s strategic platform of quality
ultrasound systems to meet a range of customer needs and offer value at every
level and price point. 

About Toshiba

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets,
sells, distributes and services diagnostic imaging systems, and coordinates
clinical diagnostic imaging research for all modalities in the United States.
Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is
a global leading provider of diagnostic medical imaging systems and
comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound,
MRI and information systems. Toshiba Corp. is a leader in information and
communications systems, electronic components, consumer products, and power
systems. Toshiba has approximately 198,000 employees worldwide and annual sales
of $77 billion. For more information, visit www.medical.toshiba.com. 

Aplio, IASSIST, ApliPure and Dynamic Flow are trademarks of Toshiba Medical
Systems Corporation.

Toshiba America Medical Systems
Charlene Jacobs, 714-669-7811
cjacobs@tams.com
or
Adrianna Hosford, 310-584-8343
adrianna.hosford@ketchum.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.